About: Ceretas Limited engages in developing a portable and non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions in Australia. The company offers a device that uses focused ultrasound beams directed through the skull to interact non-invasively with brain tissue. The company's technology operates through two primary mechanisms, including neuromodulation, which uses low-intensity focused ultrasound to stimulate neural circuits; and BBBO, which temporarily and reversibly opens the blood-brain barrier using ultrasound combined with circulating microbubbles that facilitates brain's natural clearance of amyloid-beta and tau and helps delivery of co-administered drugs to targeted brain regions. The company was incorporated in 2024 and is based in Brisbane, Australia.
Sector: Healthcare
Industry: Medical Care Facilities
Latest price: A$0.84 (+1.83%)
CTSASXCeretas Limited
Loading watchlist status…
Ceretas Limited share price
CTS price activity
Last Price
Change (24hr)
AUD (%)
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
CTS price performance
19.29%
5D
43.97%
1M
43.97%
YTD
43.97%
1Y
CTS price fundamentals
N/A
Shares Issued
N/A
Earnings Per Share (EPS)
N/A
Dividends Per Share (DPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
AU-ASX rank
N/ASector Rank
N/ACTS Market Signals